High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China
Study Details
Study Description
Brief Summary
Cardiovascular disease is the leading cause of death in China. At the village level, strategies for the control of cardiovascular disease are mostly absent. National clinical guidelines for the management of hypertension and cardiovascular disease are rarely disseminated to, or implemented by, the village primary care providers. Salt reduction has greater potential in rural China than almost anywhere else in the world. Very high levels of salt consumption, very little use of processed food and most dietary salt deriving from home cooking makes the removal of salt from the diet easier, cheaper and more worthwhile than in almost any other setting. The two large-scale cluster-randomized controlled trials proposed here will precisely and reliably define the effect of two highly plausible intervention strategies on important clinical outcomes. The evidence provided by the project will form the basis for policy setting that has the potential to greatly reduce the occurrence of vascular disease in rural China and take an important step towards balancing the rural urban divide in health and healthcare.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: High risk management
|
Behavioral: High-risk patient standardized management package
A primary-care based high cardiovascular risk management package delivered by village doctors
Other Names:
|
Experimental: Salt reduction
|
Behavioral: Community based salt reduction program
A community-based salt reduction program delivered mainly by community health educators
Other Names:
|
Experimental: high risk management and salt reduction
|
Behavioral: High-risk patient standardized management package
A primary-care based high cardiovascular risk management package delivered by village doctors
Other Names:
Behavioral: Community based salt reduction program
A community-based salt reduction program delivered mainly by community health educators
Other Names:
|
No Intervention: Usual care
|
Outcome Measures
Primary Outcome Measures
- Mean systematic blood pressure level [October 2010 - December 2012]
- 24 hour urinary sodium [October -December 2012]
Secondary Outcome Measures
- 24 hour urinary potassium [October-December 2012]
- Urinary sodium:potassium ratio [October-December 2012]
- Receiving regular primary care [October 2010 -December 2012]
- Taking anti-hypertensive medications [October 2010 -December 2012]
- Taking aspirin [October 2010 -December 2012]
- Receiving therapeutic lifestyle recommendations from village doctors [Oct 2010 - Dec 2012]
Other Outcome Measures
- Knowledge, attitude and behaviour relating to salt consumption [October-December 2012]
- Awareness, treatment, and control of hypertension [October 2010 - December 2012]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Physician-diagnosed history of coronary heart disease, ischemic stroke, or hemorrhagic stroke, or
-
Older age (50 years or older for men; 60 years or older for women) and having physician-diagnosed Type I or Type II diabetes
-
Older age (50 years or older for men; 60 years or older for women) and systolic blood pressure 160 mmHg (note that for simplicity, diastolic blood pressure is not included in the criteria)
Exclusion Criteria:
- none
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hebei Province Center for Disease Prevention and Control ,China | Shijiazhuang | Hebei | China | |
2 | The First Hospital Of China Medical University | Shenyang | Liaoning | China | |
3 | Ningxia Medical University School of Public Health | Yinchuan | Ningxia | China | |
4 | Changzhi Medical College, China | Changzhi | Shanxi | China | |
5 | The Xi'an Jiaotong University School of Public Health | Xi'an | Shanxi | China |
Sponsors and Collaborators
- The George Institute for Global Health, China
- National Heart, Lung, and Blood Institute (NHLBI)
Investigators
- Principal Investigator: Yangfeng Wu, PhD, The George Institute for Global Health, China
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Pro00025963
- HHSN268200900027C